Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRecro Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/22/2024 | Q4 2023 | N/A | -$0.01 | N/A | N/A | $27.72 M |
| 11/08/2023 | Q3 2023 | N/A | -$0.05 | N/A | N/A | $23.59 M |
| 08/14/2023 | Q2 2023 | N/A | -$0.04 | N/A | N/A | $21.80 M |
| 05/10/2023 | Q1 2023 | N/A | -$0.06 | N/A | N/A | $21.53 M |
| 03/01/2023 | Q4 2022 | N/A | -$0.16 | N/A | N/A | $24.28 M |
| 11/09/2022 | Q3 2022 | N/A | -$0.12 | N/A | N/A | $21.59 M |
| 08/10/2022 | Q2 2022 | N/A | -$0.12 | N/A | N/A | $23.15 M |
| 05/11/2022 | Q1 2022 | N/A | -$0.14 | N/A | N/A | $21.19 M |
| 03/01/2022 | Q4 2021 | -$0.07 | -$0.11 | -0.04 | N/A | $22.30 M |
| 11/09/2021 | Q3 2021 | -$0.07 | -$0.07 | 0 | N/A | $18.24 M |
| 08/09/2021 | Q2 2021 | -$0.11 | $0.03 | 0.14 | N/A | $18.02 M |
| 05/06/2021 | Q1 2021 | -$0.25 | -$0.23 | 0.02 | N/A | $16.80 M |
| 02/26/2021 | Q4 2020 | -$0.22 | -$0.48 | -0.26 | N/A | $9.91 M |
| 11/09/2020 | Q3 2020 | -$0.20 | -$0.09 | 0.11 | N/A | $19.29 M |
| 08/10/2020 | Q2 2020 | -$0.16 | -$0.25 | -0.09 | N/A | $15.52 M |
| 05/11/2020 | Q1 2020 | -$0.03 | -$0.33 | -0.3 | N/A | $21.78 M |
| 03/04/2020 | Q4 2019 | -$0.25 | -$0.41 | -0.16 | N/A | $17.64 M |
| 11/08/2019 | Q3 2019 | -$0.21 | -$0.19 | 0.02 | N/A | $25.26 M |
| 08/08/2019 | Q2 2019 | -$0.42 | -$0.13 | 0.29 | N/A | $31.26 M |
| 05/10/2019 | Q1 2019 | -$1.06 | -$0.09 | 0.97 | N/A | $25.07 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Recro Pharma, Inc. Earnings: FAQ's
Recro Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 4th, 2022 based offlast year's report dates.
The conference call for Recro Pharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Recro Pharma, Inc.'s latest earnings report can be read online.
Recro Pharma, Inc. (:REPH) has a recorded annual revenue of $94.64 M.
Recro Pharma, Inc. (:REPH) has a recorded net income of $-13,274,000.Recro Pharma, Inc. has generated $-0.14 earnings per share over the last four quarters.
Recro Pharma, Inc. (:REPH) has a price-to-earnings ratio of -7.89 and price/earnings-to-growth ratio is -0.08.